Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Assets
QFR223385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
1,802,549.00
Year-over-Year Change
9.01%
Date Range
10/1/2000 - 4/1/2025
Summary
This trend tracks the total assets of U.S. pharmaceutical and medicine corporations on a quarterly basis, providing insights into the financial health and scale of the industry. It serves as a key indicator of sector-wide investment, growth potential, and economic performance.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The total assets metric reflects the cumulative value of resources owned by pharmaceutical companies, including physical infrastructure, intellectual property, cash reserves, and investment holdings. Economists use this trend to assess industry capitalization, investment capacity, and potential for future innovation and expansion.
Methodology
Data is collected through comprehensive financial reporting by corporations, aggregated and verified by the U.S. Federal Reserve using standardized accounting principles.
Historical Context
This trend is critical for analyzing sectoral economic performance, investment attractiveness, and potential impacts on healthcare innovation and national economic strategy.
Key Facts
- Represents comprehensive financial snapshot of U.S. pharmaceutical corporate assets
- Quarterly data provides dynamic view of sector's economic performance
- Includes tangible and intangible assets across pharmaceutical corporations
FAQs
Q: What does 'total assets' include in this context?
A: Total assets encompass physical properties, cash reserves, intellectual property, investments, and other financial resources owned by pharmaceutical corporations.
Q: How frequently is this data updated?
A: The data is updated quarterly, providing a current and dynamic view of the pharmaceutical sector's financial landscape.
Q: Why are pharmaceutical corporate assets important?
A: These assets indicate the sector's capacity for research, development, innovation, and potential economic contribution.
Q: How do total assets relate to corporate performance?
A: Total assets reflect a company's financial strength, investment potential, and ability to generate future revenue and innovation.
Q: What limitations exist in this data?
A: The data provides a snapshot of assets but does not directly indicate profitability, market performance, or future growth potential.
Related Trends
Quarterly Financial Report: U.S. Corporations: Miscellaneous Manufacturing: Cash Dividends Charged to Retained Earnings This Quarter
QFR120339USNO
Quarterly Financial Report: U.S. Corporations: Basic Chemicals, Resins, and Synthetics: Other Short-Term Financial Investments
QFRD210375USNO
Quarterly Financial Report: U.S. Corporations: All Other Professional and Technical Services, Except Legal Services: Cash and Demand Deposits in the U.S.
QFR201549USNO
Quarterly Financial Report: U.S. Corporations: All Professional and Technical Services, Except Legal Services: Net Sales, Receipts, and Operating Revenues
QFR101PTSUSNO
Quarterly Financial Report: U.S. Corporations: Communications Equipment: Interest Expense
QFR105384USNO
Quarterly Financial Report: U.S. Corporations: All Nondurable Manufacturing: Net Property, Plant, and Equipment
QFR219NDUUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Assets [QFR223385USNO], retrieved from FRED.
Last Checked: 8/1/2025